Skip to content
Recall Observatory FDA recall evidence

Drug product

Digoxin Tablets, USP 125mcg, (0.125 mg), 1000-count bottle, Rx Only, Manufactured by: Novitium Pharma LLC., 70 Lake Drive, East Windsor, New Jersey 08520, NDC 70954-201-20

D-0389-2024

March 04, 2024

Class III

Product summary

Firm
Novitium Pharma LLC
Event
Event 94132
Status
Terminated
Classification
Class III
Quantity
3,940 1000-count bottles
Official record key
drug-enforcement:D-0389-2024

Official wording

Reason: Cross Contamination with Other Products:(mycophenolate mofetil).

Code information: Lot #: M23172A, Exp 01/31/2025

Distribution pattern: Nationwide in the USA

Derived failure modes

  • Unknown

    reason.no_named_rule · v1.0.0

    Cross Contamination with Other Products:(mycophenolate mofetil).